Global Scaffold Technology Market to Reach $2 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Scaffold Technology estimated at US$1. 3 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027.
New York, Dec. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Scaffold Technology Industry" - https://www.reportlinker.com/p06032835/?utm_source=GNW
Hydrogels, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$895.9 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Polymeric Scaffolds segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $370.7 Million, While China is Forecast to Grow at 6.5% CAGR
The Scaffold Technology market in the U.S. is estimated at US$370.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$352.1 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.
Micropatterned Surface Microplates Segment to Record 6.7% CAGR
In the global Micropatterned Surface Microplates segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$153.2 Million in the year 2020 will reach a projected size of US$241.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
Select Competitors (Total 34 Featured) -
3D Biotek LLC
Avacta Life Sciences Limited
Becton
Corning Inc.
Dickinson and Company
Marticel GmbH
Merck and Company
Molecular Matrix Inc.
Nanofiber Solutions
NuVasive, Inc.
Pelo Biotech GmbH
ReproCELL Europe Ltd.
Tecan Trading AG
Thermo Fisher Scientific Inc.
Read the full report: https://www.reportlinker.com/p06032835/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Scaffold Technology - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Scaffold Technology by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 2: World 7-Year Perspective for Scaffold Technology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2021 & 2027
Table 3: World Recent Past, Current & Future Analysis for
Hydrogels by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 4: World 7-Year Perspective for Hydrogels by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027
Table 5: World Recent Past, Current & Future Analysis for
Polymeric Scaffolds by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 6: World 7-Year Perspective for Polymeric Scaffolds by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Micropatterned Surface Microplates by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 8: World 7-Year Perspective for Micropatterned Surface
Microplates by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2021 & 2027
Table 9: World Recent Past, Current & Future Analysis for
Nanofiber Based Scaffolds by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 10: World 7-Year Perspective for Nanofiber Based
Scaffolds by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2021 & 2027
Table 11: World Recent Past, Current & Future Analysis for
Biotech & Pharma Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 12: World 7-Year Perspective for Biotech & Pharma
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Research Laboratories & Institutes by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 14: World 7-Year Perspective for Research Laboratories &
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2021 & 2027
Table 15: World Recent Past, Current & Future Analysis for
Hospitals & Diagnostic Centers by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 16: World 7-Year Perspective for Hospitals & Diagnostic
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2021 & 2027
Table 17: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 18: World 7-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027
Table 19: World Scaffold Technology Market Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2027
Table 20: World Recent Past, Current & Future Analysis for Stem
Cell Therapy, Regenerative Medicine, & Tissue Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 21: World 7-Year Perspective for Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for Drug
Discovery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 23: World 7-Year Perspective for Drug Discovery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027
Table 24: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 25: World 7-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 26: USA Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 27: USA 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 28: USA Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 29: USA 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 30: USA Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 31: USA 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
CANADA
Table 32: Canada Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 33: Canada 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 34: Canada Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 35: Canada 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 36: Canada Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 37: Canada 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
JAPAN
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 38: Japan Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 39: Japan 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 40: Japan Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 41: Japan 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 42: Japan Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 43: Japan 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
CHINA
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 44: China Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 45: China 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 46: China Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 47: China 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 48: China Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 49: China 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
EUROPE
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 50: Europe Recent Past, Current & Future Analysis for
Scaffold Technology by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR
Table 51: Europe 7-Year Perspective for Scaffold Technology by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2021 & 2027
Table 52: Europe Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Europe 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 54: Europe Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 55: Europe 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 56: Europe Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 57: Europe 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
FRANCE
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 58: France Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 59: France 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 60: France Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 61: France 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 62: France Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 63: France 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
GERMANY
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 64: Germany Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 65: Germany 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 66: Germany Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 67: Germany 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 68: Germany Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 69: Germany 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
ITALY
Table 70: Italy Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 71: Italy 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2021 & 2027
Table 72: Italy Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 73: Italy 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 74: Italy Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 75: Italy 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
UNITED KINGDOM
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 76: UK Recent Past, Current & Future Analysis for
Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 77: UK 7-Year Perspective for Scaffold Technology by Type -
Percentage Breakdown of Value Sales for Hydrogels, Polymeric
Scaffolds, Micropatterned Surface Microplates and Nanofiber
Based Scaffolds for the Years 2021 & 2027
Table 78: UK Recent Past, Current & Future Analysis for
Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 79: UK 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies
and Research Laboratories & Institutes for the Years 2021 &
2027
Table 80: UK Recent Past, Current & Future Analysis for
Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 81: UK 7-Year Perspective for Scaffold Technology by
Application - Percentage Breakdown of Value Sales for Stem Cell
Therapy, Regenerative Medicine, & Tissue Engineering, Drug
Discovery and Other Applications for the Years 2021 & 2027
REST OF EUROPE
Table 82: Rest of Europe Recent Past, Current & Future Analysis
for Scaffold Technology by Type - Hydrogels, Polymeric
Scaffolds, Micropatterned Surface Microplates and Nanofiber
Based Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 83: Rest of Europe 7-Year Perspective for Scaffold
Technology by Type - Percentage Breakdown of Value Sales for
Hydrogels, Polymeric Scaffolds, Micropatterned Surface
Microplates and Nanofiber Based Scaffolds for the Years 2021 &
2027
Table 84: Rest of Europe Recent Past, Current & Future Analysis
for Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 85: Rest of Europe 7-Year Perspective for Scaffold
Technology by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Diagnostic Centers, Other End-Uses, Biotech &
Pharma Companies and Research Laboratories & Institutes for the
Years 2021 & 2027
Table 86: Rest of Europe Recent Past, Current & Future Analysis
for Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 87: Rest of Europe 7-Year Perspective for Scaffold
Technology by Application - Percentage Breakdown of Value Sales
for Stem Cell Therapy, Regenerative Medicine, & Tissue
Engineering, Drug Discovery and Other Applications for the
Years 2021 & 2027
ASIA-PACIFIC
Scaffold Technology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 88: Asia-Pacific Recent Past, Current & Future Analysis
for Scaffold Technology by Type - Hydrogels, Polymeric
Scaffolds, Micropatterned Surface Microplates and Nanofiber
Based Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 89: Asia-Pacific 7-Year Perspective for Scaffold
Technology by Type - Percentage Breakdown of Value Sales for
Hydrogels, Polymeric Scaffolds, Micropatterned Surface
Microplates and Nanofiber Based Scaffolds for the Years 2021 &
2027
Table 90: Asia-Pacific Recent Past, Current & Future Analysis
for Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 91: Asia-Pacific 7-Year Perspective for Scaffold
Technology by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Diagnostic Centers, Other End-Uses, Biotech &
Pharma Companies and Research Laboratories & Institutes for the
Years 2021 & 2027
Table 92: Asia-Pacific Recent Past, Current & Future Analysis
for Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 93: Asia-Pacific 7-Year Perspective for Scaffold
Technology by Application - Percentage Breakdown of Value Sales
for Stem Cell Therapy, Regenerative Medicine, & Tissue
Engineering, Drug Discovery and Other Applications for the
Years 2021 & 2027
REST OF WORLD
Table 94: Rest of World Recent Past, Current & Future Analysis
for Scaffold Technology by Type - Hydrogels, Polymeric
Scaffolds, Micropatterned Surface Microplates and Nanofiber
Based Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Rest of World 7-Year Perspective for Scaffold
Technology by Type - Percentage Breakdown of Value Sales for
Hydrogels, Polymeric Scaffolds, Micropatterned Surface
Microplates and Nanofiber Based Scaffolds for the Years 2021 &
2027
Table 96: Rest of World Recent Past, Current & Future Analysis
for Scaffold Technology by End-Use - Hospitals & Diagnostic
Centers, Other End-Uses, Biotech & Pharma Companies and
Research Laboratories & Institutes - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 97: Rest of World 7-Year Perspective for Scaffold
Technology by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Diagnostic Centers, Other End-Uses, Biotech &
Pharma Companies and Research Laboratories & Institutes for the
Years 2021 & 2027
Table 98: Rest of World Recent Past, Current & Future Analysis
for Scaffold Technology by Application - Stem Cell Therapy,
Regenerative Medicine, & Tissue Engineering, Drug Discovery and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 99: Rest of World 7-Year Perspective for Scaffold
Technology by Application - Percentage Breakdown of Value Sales
for Stem Cell Therapy, Regenerative Medicine, & Tissue
Engineering, Drug Discovery and Other Applications for the
Years 2021 & 2027
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032835/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Gloss